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The Effect of Diazoxide, Potassium Chloride, and 
Ammonium Chloride on Serum and Urinary Uric Acid 
By GEORGE R. THOMPSON, M.D. 
Dept. of Internal Medicine, University of Michigan Medical School 
I would like to tell you about two studies in which we have recently 
been involved, at the University of Michigan. The first concerns the effects 
of diazoxide on uric acid excretion. Diazoxide is chemically similar to 
chlorothiazide (Fig. l O l ) ,  differing by the absence of a free sulfamyl group. 
However, its pharmacologic effects are quite different. Studies following the 
oral administration of diazoxide have shown that it lowers blood pressure, as 
does chlorothiazide, but has antidiuretic properties, decreasing sodium, potas- 
sium and chloride e~cretion.l-~ It has also been found to produce hypergly- 
cemia, to an extent prohibiting its usefulness for chronic 
However, intravenously it produces a prompt fall in blood pressure and has 
thus been recommended for the treatment of hypertensive crisis.? 
The effect of intravenous diazoxide upon blood pressure, electrolyte, and 
uric acid excretion was studied, but only the last will be recorded here in 
any detail. The effects of 300 mg. of diazoxide (the usual recommended dose) 
was studied in nine subjects; one subject received 600 mg. and another 300 mg. 
of intravenous diazoxide plus 1.5 Gm. of oral probenecid. The effect of 
300 mg. of chlorothiazide given intravenously was also studied in four of 
these subjects. 
Figure 102 depicts the changes in urinary uric acid. Both 30 mg. and 600 mg. 
doses of diazoxide produced a decrease in urate excretion. This effect was 
completely blocked by probenecid. Chlorothiazide, given intravenously, 
produced a urate diuresis, as has been previously demonstrated by Dr. 
Demartini.8 The urate clearance: creatinine clearance ratio was similarly af- 
fected (Fig. 103), demonstrating that these changes in uric acid excretion were 
not solely due to changes in the glomerular filtration rate. 
The effects of these two drugs are compared and summarized in Fig. 104. 
We postulate that diazoxide in 300 mg. and 600 mg. doses decreases urate 
excretion by blocking renal tubular secretion of uric acid. Intravenous chloro- 
c1 
Diazoxide Chloro thiazi de 
Fig. 101.-Chemical structure of diazoxide and chlorothiazide. 
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Fig. 102.-Urinary excretion of uric acid, expressed as milligrams of uric acid per 
three hour collection of urine. A control specimen was obtained, following which 
the drug was given, and two subsequent three hour specimens obtained. 
thiazide, however, produces a mate diuresis by also blocking tubular reab- 
sorption of uric acid (oral chlorothiazide, presumably due to lower blood 
concentration, causes urate retention by only blocking tubular secretion). 
The second study concerns the effect of potassium chloride and ammonium 
chloride on thiazide hyperuricemia. This study was carried out in the Clinical 
Research Unit at the University of Michigan Medical Center in conjunction 
with Dr. Andrew J. Zweifler. 
It has been reported that large doses of potassium chloride lower serum 
uric acid concentration in patients receiving the thiazide d i u r e t i c ~ . ~ J ~  We 
attempted to confirm this, and hopefully to find an explanation. Four subjects 
receiving chlorothiazide for at least one month were studied, as were two 
control subjects not receiving the clrug. Following base line studies, the sub- 
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as the syrup. Each salt was given separately for 3 to 5 days, with a control 
period between the experiments. 
As seen in Table 22, following potassium chloride administration, serum uric 
acid fell substantially in 3 of the 4 thiazide-treated patients, but only slightly in 
the fourth. A mild decrement was also observed in one of the control subjects. 
These changes were accompanied by rises in the urinary uric acid and urate 
clearance: creatinine clearance ratio. 
However, subject F. B. experienced a marked fall in serum uric acid 
(2.0 mg. per cent), while the mean urinary uric acid rose only 13 mg. per 
24 hours. The serum uric acid decreased 1.75 mg. per cent in subject J. M., 
accompanied by a mild uricosuria, but the subsequent rise to pre-treatment 
levels following discontinuation of potassium chloride was accompanied by 
only minimal changes in urate excretion. Subject L. A.’s serum uric acid 
dropped 1 mg. per cent during the first 24 hours of potassium chloride ad- 
ministration, yet the urinary excretion of uric acid was unaltered during this 
same period. Subsequently, she did develop a urate diuresis. 
Serum uric acid decreased in all subjects during ammonium chloride ad- 
ministration (Table 23). In those receiving chlorothiazide this response was 
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Fig. 104.--Summary and comparison of the effects of intravenous diazoxide and 
chlorothiazide. 
generally less than that produced by potassium chloride, while the reverse 
was true in those subjects not taking the diuretic. Urinary excretion of uric 
acid either decreased or remained unchanged in all subjects except J. h4. 
Serum sodium and potassium levels were altered very little by ammonium 
chloride, though there was a tendency to increased urinary excretion of these 
electrolytes. Serum carbon dioxide combining power was decreased. Urine 
volume was substantially increased. 
These data confirm that potassium chloride does lower serum uric acid in 
thiazide-treated individuals, while, in our experience, having little influence on 
subjects not receiving this drug. Further, this effect is not solely due to in- 
creased urinary excretion of uric acid, as it can appear in the absence of 
uricosuria and subside without subsequent urate retention. Potassium chloride 
also produces a mild uricosuria, of similar magnitude in both normal subjects 
and those taking chlorothiazide. 
These effects were not correlated with changes in serum potassium con- 
centration, as equivalent elevation of serum potassium was produced by 
spironolactone without effect on serum uric acid. Also, impressive decrements 
of serum uric acid occurred which were accompanied by only minor rises in 
serum potassium. 
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Urine uric acid (mg./24") 
Pre-KC1 KC1 Change 
_______- 
180 430 $250 
1260 1273 $13 
350 463 +113 
425 653 +228 
Table 22.-E$ect of Potassium Chloride (160 mEq./d.) on 
Serum and Urinary Uric Acid 
Urate Clearance: 
Creatinine Clearance 
(Expressed as per cent) 
Pre-KC1 KC1 Change 
6.50 12.90 +6.40 
7.40 8.66 +1.26 
5.70 7.80 +2.10 
4.50 6.85 +2.35 
_____ Serum uric acid (mg. %) - 
Subjects Pre-KC1 KCl Change 
Urine uric acid (mg./24') 
Pre-NHaCl NHpCl Change 
_____ - 
340 260 -80 
923 922 -1 
307 420 +113 
490 420 -70 
773 683 -90 
833 770 -63 
L. A.' 6.96 4.85 -2.11 
F. B." 7.33 5.30 -2.03 
J. M.* 6.05 4.30 -1.75 
c. w.* 5.28 4.60 -0.68 
Urate Clearance: 
Creatinine Clearance 
(Expressed as per cent) 
Pre-NH&1 NH4Cl Change 
- 
6.80 6.46 +0.66 
5.60 6.90 +0.30 
5.20 6.05 +0.85 
3.87 3.54 -0.33 
6.60 4.90 -0.70 
5.80 5.43 -0.37 
M. W. 5.55 5.50 -0.05 
R. S. 6.60 5.95 -0.65 
7s5 857 6.20 6.84 $0.64 
633 826 +193 +" 1 4.85 6.49 +1.64 
"Thiazide treated. 
Table 23.-Eflect of Ammonium Chloride (12.0 Gm. /d . )  on 
Serum and Urinary Uric Acid 
Serum uric acid (mg. %) 
Subjects Pre-NH&l NHaCl Change 
L. A.* 7.50 5.45 -2.05 
F. B.* 8.06 7.15 -0.91 
J. M.* 5.43 4.65 -0.78 
C. w.* 6.23 5.25 -1.08 
M. W. 6.40 5.95 -0.45 
R. S. 6.47 5.35 -1.12 
*Thiazide treated. 
No significant alterations in blood pH or bicarbonate content occurred. 
However, the subjects experiencing the greatest hypouricemic response to 
potassium chloride excreted a smaller proportion of the potassium load than 
did those who had a lesser response. This suggested that the hypouricernic 
effect of potassium chloride might be related to its ability to correct intra- 
cellular potassium deficiency, and thus intracellular alkalosis. Ammonium 
chloride produced an increase in blood acidity. 
With the aid of two basic assumptions, the effects of potassium chloride 
and ammonium chloride may be explained. These are: ( a )  that uric acid 
movement across cell membranes is determined by the H+ ion gradient 
across the cell membrane and ( b )  that cells are potassium-depleted, and 
relatively acidotic, in certain thiazide-treated subjects. 
Uric acid is a weak acid. It has been demonstratedll that biologic mem- 
branes are more permeable to un-ionized than ionized weak acids and bases, 
therefore allowing concentration gradients to develop if there is a difference 
in hydrogen ion concentration between the two sides of the membrane. Weak 
acids will tend to accumulate on the alkaline side. Dr. Lassen in Denmark 
has shown that uric acid transport into human erythrocytes is accelerated by 
lowering extracellular pH.12 
Accepting these asumptions, the following interpretation of our data may 
be rendered: 
1) Potassium chloride administration lowers serum uric acid in those 
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thiazide-treated individuals who are potassium depleted, because it tends to 
correct this deficiency, thereby elevating intracellular pH, resulting in uric 
acid movement into cells from the extracellular fluid. 
2 )  Ammonium chloride lowers serum uric acid in all subjects because it 
produces extracellular acidosis, while having little effect on intracellular pH, 
thereby inducing movement of uric acid into the cells, now relatively more 
alkaline than the extracellular fluid. 
If these assumptions are correct, they explain our data, and the observations 
of Dr. Ayvazian13 and others14 that serum uric acid concentration rises during 
thiazide treatment while there is yet no decrease in urinary uric acid excretion. 
We have not, of course, excluded the possibilities that large doses of potassium 
chloride may either decrease production of uric acid or increase its nonrenal 
excretion. 
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